About 353 results

ALLMedicine™ Iron-binding Capacity Center

Research & Reviews  125 results

Erythropoietic effects of vadadustat in patients with anemia associated with chronic ki...
American Journal of Hematology; Koury MJ, Agarwal R et. al.

Jun 26th, 2022 - Patients with chronic kidney disease develop anemia largely because of inappropriately low erythropoietin production and insufficient iron available to erythroid precursors. In four phase 3, randomized, open-label, clinical trials in dialysis-depe...

Comparison of daily oral iron replacement therapy with every other day treatment in fem...
https://doi.org/10.1007/s00277-022-04835-6 10.1016/S0140-6736(17)32154-2 10.1016/j.beha.2004.08.022 10.4314/ajtcam.v11i2.19 10.1016/S2352-3026(17)30182-5 10.1136/gutjnl-2021-325210 10.1182/blood-2015-05-642223 10.1111/imj.14766 10.1172/JCI200420945 10.1182/blood-2007-04-087593 10.3945/ajcn.2009.28129 10.1007/s00277-019-03871-z 10.1093/ajcn/62.1.117
Annals of Hematology; Kaynar LA, Gökçen S et. al.

Apr 24th, 2022 - Iron-deficiency anemia (IDA) is accepted as the most common cause of anemia in the world. The main goals of iron replacement therapy are to normalize the hemoglobin level and to replace iron stores. Current guidelines for treating iron deficiency ...

The interaction analysis between advanced age and longer dialysis vintage on the surviv...
The Journal of International Medical Research; Wu Y, Huang B et. al.

Apr 14th, 2022 - To compare the all-cause mortality of aged and younger patients undergoing maintenance hemodialysis (MHD) over the long or short term, and to identify independent risk factors. We performed a retrospective cohort study using the medical records of...

The efficacy and safety of roxadustat for the treatment of anemia in non-dialysis depen...
PloS One; Abdelazeem B, Shehata J et. al.

Apr 2nd, 2022 - Roxadustat (ROX) is a new medication for anemia as a complication of chronic kidney disease (CKD). Our meta-analysis aims to evaluate the efficacy and safety of ROX, especially on the cardiovascular risks, for anemia in NDD-CKD patients. Electroni...

see more →

Clinicaltrials.gov  4 results

Intravenous Iron Infusion on Chemotherapy-induced Anemia

Mar 29th, 2022 - FOLFOX, the first-line regimen based on 5-FU and oxaliplatin, is adjuvant chemotherapy for pathologic stage II/III colorectal cancer patients. Among various side effects of FOLFOX, chemotherapy-induced anemia occurs in about 30% of patients with F...

The Role of Hepcidin as a Biomarker to Predict Successful Renal Transplantation

Oct 5th, 2020 - POD-1 : Researchers will meet patients scheduled for surgery and explain the study. (enroll) the operation date : The patient will sign the consent form. Researchers will collect the blood sample from the patient for testing hepcidin during the op...

Quality of Life in Premenopausal Women With Heavy Menstrual Bleeding

Sep 24th, 2020 - Women who were admitted and treated for HMB were asked to participate in this comparative study. Women were eligible for entry if they had self-described heavy menstrual bleeding, had a regular cycle, had completed their family and were 40-50 year...

The Correlation Between Anemia of Chronic Diseases, Hepcidin and Vitamin D in IBD Patients

May 9th, 2017 - Crohn's disease (CD) and ulcerative colitis (UC) are chronic gastrointestinal diseases characterized by relapsing and remitting inflammation of the intestines . Anemia may often complicate the course of inflammatory bowel disease (IBD) . A recent ...

see more →

News  12 results

Blistering Disease During the Treatment of Chronic Hepatitis C With Ledipasvir/Sofosbuvir
Joshua Cash, MD, Ashley Skinner et. al.

Mar 1st, 2020 - Porphyria cutanea tarda (PCT) is the most common type of porphyria. The accumulation of porphyrin in various organ systems results from a deficiency of uroporphyrinogen decarboxylase (UROD).

Quercetin may reduce iron overload in beta-thalassemia major
Caleb Rans

Aug 28th, 2019 - Combination quercetin and desferrioxamine could decrease iron overload in patients with transfusion-dependent beta-thalassemia major, according to a randomized clinical study. Over the course of treatment, quercetin was well tolerated and no major.

Ferrous sulfate bests iron complex in treating IDA in infants, young kids
HT Staff

Jun 15th, 2017 - Ferrous sulfate drops A trial comparing ferrous sulfate with iron polysaccharide complex to treat infants and young children with nutritional iron-deficiency anemia (IDA) has shown ferrous sulfate to be more effective at raising hemoglobin levels.

Ferrous Sulfate Superior Tx for Kids with Iron-Deficiency Anemia (JAMA)

Jun 13th, 2017 - Once daily ferrous sulfate was superior to iron polysaccharide when given to young kids with nutritional iron deficiency anemia, a small trial found. Researchers writing in the Journal of the American Medical Association found that children ages 9...

A Fatal Case of Intractable Anemia

Sep 25th, 2013 - Clinical Presentation The patient was a 33-year-old, well-conditioned male athlete who presented to a referring hospital with a 4-day history of fatigue, lethargy, fever, chills, jaundice, dark urine, and abdominal pain. His medical history includ...

see more →